Relapsing polychondritis (clinical observations)
https://doi.org/10.47360/1995-4484-2024-237-243
Abstract
Relapsing polychondritis (RPC) is an autoimmune disease manifested by both repeated attacks and a persistent inflammatory process with progressive destruction of cartilaginous structures, in particular, chondritis of the ears, nose, larynx, bronchi, and joints. RPC is a rare disease (about 1000 cases have been described worldwide). Diagnosis of RPC and the choice of treatment tactics are very difficult, which is associated with the rarity of the pathology, undulating, unpredictable course, and the lack of specific laboratory markers.
The clinical observations presented in the article confirm the complexity of diagnosing RPC. Before the disease was verified, both patients repeatedly consulted different specialists: the first patient was diagnosed 3 months after the onset of characteristic symptoms of RPC, and the second patient – 1.5 years later. Late diagnosis and the lack of a unified approach to treatment were the reason for the development of prognostically unfavorable lesions in the second patient – chondritis and perichondritis of the larynx.
About the Authors
Е. N. Skryabina
Saratov State Medical University named after V.I. Razumovsky
Russian Federation
Russian Federation
Elena N. Skryabina
410012, Saratov, Bolshaya Kazachya str., 112
О. L. Aleksandrova
Saratov State Medical University named after V.I. Razumovsky
Russian Federation
Russian Federation
Olga L. Aleksandrova
410012, Saratov, Bolshaya Kazachya str., 112
I. А. Romanova
Saratov State Medical University named after V.I. Razumovsky
Russian Federation
Russian Federation
Irina A. Romanova
410012, Saratov, Bolshaya Kazachya str., 112
А. Р. Rebrov
Saratov State Medical University named after V.I. Razumovsky
Russian Federation
Russian Federation
Andrey P. Rebrov
410012, Saratov, Bolshaya Kazachya str., 112
N. М. Nikitina
Saratov State Medical University named after V.I. Razumovsky
Russian Federation
Russian Federation
Natalia M. Nikitina
410012, Saratov, Bolshaya Kazachya str., 112
References
1. Longo L, Greco A, Rea A, LoVasco VR, De Virgilio A, De Vincentiis M. Relapsing polychondritis: A clinical update. Autoimmun Rev. 2016;15(6):539-543. doi: 10.1016/j.autrev.2016.02.013
2. Sharma A, Gnanapandithan K, Sharma K, Sharma S. Relapsing polychondritis: A review. Clin Rheumatol. 2013;32(11):1575-1583. doi: 10.1007/s10067-013-2328-x
3. Meshkov AD, Zhilyaev EV, Novikov PI. Experience of successful treatment of relapsing polychondritis with tofacitinib. Therapist’s Bulletin. 2023;1(56):20-29 (In Russ.)
4. Baev VM, Nechaeva MG, Druzhina LN. Clinical case of relapsing polychondritis. Difficult Patient. 2020;18(5):55-58 (In Russ.)
5. Jaksch-Wartenhorst R. Polychondropathia. Wien Arch Inn Med. 1923;6:93-100.
6. Pearson CM, Kline HM, Newcomer VD. Relapsing polychondritis. N Engl J Med. 1960;263:51-58. doi: 10.1056/NEJM196007142630201
7. Foidart JM, Abe S, Martin GR, Zizic TM, Barnett EV, Lawley TJ, et al. Antibodies to type II collagen in relapsing polychondritis. N Engl J Med. 1978;299(22):1203-1207. doi: 10.1056/NEJM197811302992202
8. Buckner JH, Van Landeghen M, Kwok WW, Tsarknaridis L. Identification of type II collagen peptide-specific T cell clones in a patient with relapsing polychrondritis. Arthritis Rheum. 2002;46:238-244.
9. Shilkina NP, Masina IV, Osipova SYu, Klokov AV. Relapsing polychondritis in rheumatology practice. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2018;56(2):253-256 (In Russ.)
10. Nasonov EL. New possibilities of pharmacotherapy for immunoinflammatory rheumatic diseases: A focus on inhibitors of interleukin-17. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2017;55(1):68-86 (In Russ.)
11. Chernyak VI, Savelyev AI, Pogromov AP, Menshikova IV, Narkevich KV. Relapsing polychondritis. Clinical Medicine (Russian Journal). 2014;92(11):22-28 (In Russ.)
12. Saykovskiy RS, Babak VV, Grigor’eva MA. Relapsing polychondritis. The case of practice. Clinical Practice. 2011;4:44-49 (In Russ.)
13. Lei W, Zeng H, Zeng DX, Zhang B, Zhu YH, Jiang JH, et al. (18) F-FDG PET-CT: A powerful tool for the diagnosis and treatment of relapsing polychondritis. Br J Radiol. 2016;89(1057):20150695. doi: 10.1259/bjr.20150695
14. Wang J, Li S, Zeng Y, Chen P, Zhang N, Zhong N. 18F-FDG PET/CT is a valuable tool for relapsing polychondritis diagnose and therapeutic response monitoring. Ann Nucl Med. 2014;28(3):276-284. doi: 10.1007/s12149-014-0805-1
15. McAdam LP, O’Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: Prospective study of 23 patients and a review of the literature. Medicine (Baltimore). 1976;55(3):193-215.
16. Damiani JM, Levine HL. Relapsing polychondritis – Report of ten cases. Laryngoscope. 1979;89(6 Pt 1):929-946.
17. Michet CJ, McKenna CH, Luthra HS, O’Fallon WM. Relapsing polychondritis: Survival and predictive role of early disease manifestations. Ann Intern Med. 1986;104(1):74-78. doi: 10.7326/0003-4819-104-1-74
18. Semizarova IV, Eliseeva LN, Davydova AF, Baste ZA, Kisian ZhA. Rare rheumatic diseases. Relapsing polychondritis: A clinical case. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2019;57(4):478- 481 (In Russ.)
Review
For citations:
Skryabina Е.N., Aleksandrova О.L., Romanova I.А., Rebrov А.Р., Nikitina N.М. Relapsing polychondritis (clinical observations). Rheumatology Science and Practice. 2024;62(2):237-243. (In Russ.) https://doi.org/10.47360/1995-4484-2024-237-243
Views:
1025
Email this article 